KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Capital Employed (2016 - 2025)

Pacira BioSciences has reported Return on Capital Employed over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.02% for Q4 2025, up 8.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (up 8.0% YoY), and the annual figure for FY2025 was 0.01%, up 7.0%.
  • Return on Capital Employed for Q4 2025 was 0.02% at Pacira BioSciences, down from 0.03% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PCRX hit a ceiling of 0.09% in Q3 2021 and a floor of 0.08% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 0.04% (2022), compared with a mean of 0.03%.
  • Peak annual rise in Return on Capital Employed hit 8bps in 2025, while the deepest fall reached -14bps in 2025.
  • Pacira BioSciences' Return on Capital Employed stood at 0.08% in 2021, then crashed by -49bps to 0.04% in 2022, then skyrocketed by 56bps to 0.06% in 2023, then crashed by -199bps to 0.06% in 2024, then surged by 128bps to 0.02% in 2025.
  • The last three reported values for Return on Capital Employed were 0.02% (Q4 2025), 0.03% (Q3 2025), and 0.08% (Q2 2025) per Business Quant data.